2021
DOI: 10.3390/jcm10153410
|View full text |Cite
|
Sign up to set email alerts
|

Current and Prospective Treatment of Adenomyosis

Abstract: (1) Background: Adenomyosis is a poorly understood entity which makes it difficult to standardize treatment. In this paper we review and compare the currently approved medical and surgical treatments of adenomyosis and present the evidence behind them. (2) Methods: A PubMed search was conducted to identify papers related to the different treatments of adenomyosis. The search was limited to the English language. Articles were divided into medical and surgical treatments. (3) Results: Several treatment options h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
39
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(39 citation statements)
references
References 89 publications
(116 reference statements)
0
39
0
Order By: Relevance
“…Since the IIA provides the main blood supply to the uterus, it is also crucial in the development of a range of uterine pathologies such as adenomyosis [15] and uterine broids [16]. Both those conditions are exacerbated by an excessive blood supply from the uterine artery, which is why uterine artery embolization (UAE) provides effective treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Since the IIA provides the main blood supply to the uterus, it is also crucial in the development of a range of uterine pathologies such as adenomyosis [15] and uterine broids [16]. Both those conditions are exacerbated by an excessive blood supply from the uterine artery, which is why uterine artery embolization (UAE) provides effective treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Current therapeutic options mostly rely on conservative hormonal therapies. Hereby, combined hormonal therapy and, especially, progestins seems to represent the cornerstone of medications, being also able to inhibit cell proliferation, inflammation, neurogenesis and neovascularization in endometriosis ( 12 , 13 ). However, for yet unclear mechanisms, some forms seem to be characterized by progesterone resistance, being thus refractory to conventional medical therapy ( 14 ).…”
Section: Discussionmentioning
confidence: 99%
“…The progression of adenomyosis lesions with hypertrophic myometrium is enhanced by estrogen and abrogated by progesterone [ 136 ]. For those reasons, hormonal treatments such as GnRH agonists, progestins, and oral contraceptives have been used to suppress pain symptoms and abnormal heavy menorrhagia [ 132 , 151 , 152 ]. GnRH agonists are effective in causing systemic hypoestrogenism to reduce the size of adenomyosis and improve adenomyosis-associated symptoms [ 153 , 154 , 155 ], whereas the side effects of GnRH agonists (menopausal symptoms) limit their use.…”
Section: Adenomyosismentioning
confidence: 99%
“…LNG-IUD has been considered most effective and successfully used to treat adenomyosis because it is efficient in suppressing menstrual bleeding [ 156 , 157 , 158 , 159 , 160 ]. The efficacy of LNG-IUD is generally higher than other progestin-based treatments [ 151 , 152 ]. This is because LNG-IUD consistently suppresses the menstrual cycle.…”
Section: Adenomyosismentioning
confidence: 99%